GORAN ANDO - 02 Jan 2023 Form 4 Insider Report for SELECTA BIOSCIENCES INC (RNAC)

Role
Director
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Goran Ando, M.D.
Issuer symbol
RNAC
Transactions as of
02 Jan 2023
Net transactions value
$0
Form type
4
Filing time
04 Jan 2023, 16:04:42 UTC
Previous filing
11 Feb 2022
Next filing
13 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SELB Stock Option (Right to Buy) Award $0 +75,000 $0.000000 75,000 02 Jan 2023 Common Stock 75,000 $1.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock underlying this award will vest in full on January 2, 2024.